Test a sentinel lymph node biopsy in early ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies whether taking a sample from the sentinel lymph node during surgery can help with staging early ovarian cancer. It may help doctors find spread to lymph nodes more accurately while limiting unnecessary lymph node removal in some cases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a concerning (suspicious) ovarian/adnexal mass that could be early-stage ovarian cancer
- Doctors believe you can safely undergo surgery, including lymph node biopsy and a full lymph node staging procedure if needed
- Your mass is not considered unlikely to be early-stage ovarian cancer
- You do not have signs of ovarian cancer that has already come back (recurrent cancer)
- There is no sign you had advanced ovarian cancer already (FIGO stage III or IV), and you have not had chemotherapy before surgery (neoadjuvant treatment)
- This is not a situation where you have another metastatic cancer or more than one new ovarian cancer at different times (double primary/metachronous)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a less invasive way to check if cancer has spread to lymph nodes (sentinel node biopsy) works as well as the standard method. It is for people with early-stage endometrial cancer having surgery.
This trial studies whether very small deposits of cancer (called micrometastasis or isolated tumor cells) are found in sentinel lymph nodes in early endometrial or cervical cancer. The goal is to better understand what these findings may mean for cancer spread and treatment planning.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
This trial compares a fast lab test (OSNA) with standard microscope checks to see which better finds cancer in the first lymph node (sentinel node) during surgery for early-stage endometrial cancer. It aims to improve accuracy and speed while avoiding unnecessary lymph node removal.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
Hear when a new Sentinel Lymph Node trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.